Join to View Full Profile
1033 Westlake DrKannapolis, NC 28081
Phone+1 704-785-6805
Dr. Sartiano is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Retired; Former Professor of Medicine, and Director, Division of Hematology and Oncology, Department of Medicine, University of South Carolina School of Medicine
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 1968 - 1970
Memorial Sloan Kettering Cancer CenterResidency, Lymphoma/Hematology Fellow and Research Fellow, 1963 - 1964
NYU Grossman School of Medicine (Veterans)Residency, Internal Medicine, 1961 - 1963
One Brooklyn Health System/Interfaith Medical CenterInternship, Internal Medicine, 1960 - 1961- New York University School of MedicineClass of 1960
Certifications & Licensure
NC State Medical License 1989 - 2025
NY State Medical License 1961 - 2014
SC State Medical License 1976 - 1993
PA State Medical License 1970 - 1978
Awards, Honors, & Recognition
- Phi Beta Kappa
- Saint Augustine D.H.S. Hall of Fame Bishop Loughlin D.H.S, 2014
- E. Lipson - Siegel Award in Biochemistry Brooklyn College of CUNY, 1956
Publications & Presentations
PubMed
- 95 citationsProlonged Single-Agent Versus Combination Chemotherapy in Indolent Follicular Lymphomas: A Study of the Cancer and Leukemia Group BBruce A. Peterson, Gina R. Petroni, Glauco Frizzera, Maurice Barcos, Clara D. Bloomfield
Journal of Clinical Oncology. 2003-01-01 - 8 citationsA multicenter phase II trial of losoxantrone (DuP-941) in hormone-refractory metastatic prostate cancer.Susan D. Huan, Ronald B. Natale, David J. Stewart, George P. Sartiano, Philip J. Stella
Clinical Cancer Research. 2000-04-01 - 13 citationsLow-dose cytosine arabinoside as an alternative treatment for acute leukemia in Jehovah's Witnesses.Paul M. Dainer, Charles Knupp, George P. Sartiano
American Journal of Hematology. 1992-06-01
Professional Memberships
- American College of PharmacologyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
